AVE SCIENCE&TECHNOLOGY CO.,LTD Financials AVE Science&Technology CO.,LTD
Equities
688067
CNE100005188
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.14 CNY | +1.72% |
|
+2.02% | -28.01% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 1,891 | 1,274 | 1,619 |
| Enterprise Value (EV) 1 | 1,598 | 1,019 | 1,381 |
| P/E ratio | 52.5 x | 72 x | 74.4 x |
| Yield | 1.08% | 0.53% | 0.42% |
| Capitalization / Revenue | 8.98 x | 6.47 x | 8.08 x |
| EV / Revenue | 7.58 x | 5.18 x | 6.89 x |
| EV / EBITDA | 51.3 x | 79.2 x | 61.6 x |
| EV / FCF | 245 x | -42.5 x | 42.6 x |
| FCF Yield | 0.41% | -2.35% | 2.35% |
| Price to Book | 3.96 x | 2.68 x | 3.31 x |
| Nbr of stocks (in thousands) | 68,000 | 68,000 | 68,000 |
| Reference price 2 | 27.81 | 18.73 | 23.81 |
| Announcement Date | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 151.4 | 190 | 180.2 | 210.7 | 196.8 | 200.3 |
| EBITDA 1 | 30.22 | 57.75 | 34.58 | 31.15 | 12.86 | 22.43 |
| EBIT 1 | 25.74 | 57.23 | 29.13 | 24.73 | 4.105 | 11.83 |
| Operating Margin | 17.01% | 30.12% | 16.16% | 11.74% | 2.09% | 5.91% |
| Earnings before Tax (EBT) 1 | 28.89 | 57.15 | 33.56 | 33.91 | 18.2 | 22.36 |
| Net income 1 | 26.34 | 50.52 | 30.1 | 31.28 | 17.97 | 21.53 |
| Net margin | 17.4% | 26.59% | 16.7% | 14.85% | 9.13% | 10.75% |
| EPS 2 | 0.5165 | 0.9900 | 0.5900 | 0.5300 | 0.2600 | 0.3200 |
| Free Cash Flow 1 | 8.158 | -13.98 | 16.87 | 6.531 | -23.97 | 32.42 |
| FCF margin | 5.39% | -7.36% | 9.36% | 3.1% | -12.18% | 16.19% |
| FCF Conversion (EBITDA) | 26.99% | - | 48.77% | 20.96% | - | 144.53% |
| FCF Conversion (Net income) | 30.97% | - | 56.04% | 20.88% | - | 150.55% |
| Dividend per Share 2 | 0.3000 | - | - | 0.3000 | 0.1000 | 0.1000 |
| Announcement Date | 4/24/19 | 3/13/20 | 5/25/21 | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 53 | 33.5 | 59.8 | 293 | 255 | 238 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 8.16 | -14 | 16.9 | 6.53 | -24 | 32.4 |
| ROE (net income / shareholders' equity) | 12.7% | 21.5% | 12.3% | 8.76% | 3.77% | 4.46% |
| ROA (Net income/ Total Assets) | 6.68% | 12.9% | 6.13% | 3.66% | 0.47% | 1.34% |
| Assets 1 | 394.1 | 392.1 | 491.1 | 854.2 | 3,844 | 1,611 |
| Book Value Per Share 2 | 4.340 | 4.970 | 4.640 | 7.020 | 6.990 | 7.200 |
| Cash Flow per Share 2 | 0.8400 | 0.6600 | 0.4900 | 3.360 | 2.200 | 1.220 |
| Capex 1 | 17.4 | 24.5 | 11.8 | 20.5 | 21.2 | 4.5 |
| Capex / Sales | 11.48% | 12.89% | 6.55% | 9.74% | 10.78% | 2.25% |
| Announcement Date | 4/24/19 | 3/13/20 | 5/25/21 | 4/27/22 | 4/26/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -28.01% | 161M | |
| -4.67% | 12.32B | |
| -5.19% | 8.07B | |
| +28.50% | 5.52B | |
| -8.09% | 4.21B | |
| -55.31% | 2.99B | |
| +13.49% | 2.73B | |
| -1.34% | 2.43B | |
| +32.24% | 2.29B | |
| -3.55% | 1.89B |
- Stock Market
- Equities
- 688067 Stock
- Financials AVE Science&Technology CO.,LTD
